Baidu
map

Psychooncology:年轻癌症患者过的“性福”吗?

2015-11-01 Seven L 译 MedSci原创

最近几年对年轻癌症患者(AYA)的关注越来越多,不过大部分研究集中在AYAs的生育问题上,对该类人群浪漫关系和性方面的研究则很少。研究者进行了一项横断面研究调查AYAs人群的关系情况和性满意度,进而识别该类人群的性别差异。研究共纳入了99名年轻癌症患者,年龄在15-39岁之间,其中33名为男性。在调查期间参与者有浪漫对象,并且完成了关于其对象关系、性活动、性欲的问卷调查。研究数据显示,75名患者对

最近几年对年轻癌症患者(AYA)的关注越来越多,不过大部分研究集中在生育问题上,对该类人群浪漫关系和性方面的研究则很少。研究者进行了一项横断面研究调查AYAs人群的关系情况和性满意度,进而识别该类人群的性别差异。

研究共纳入了99名年轻癌症患者,年龄在15-39岁之间,其中33名为男性。在调查期间参与者有浪漫对象,并且完成了关于其对象关系、性活动、性欲的问卷调查。

研究数据显示,75名患者对其伴侣关系评价很高,64%的患者指出自从诊断为癌症后,性活动频率减少,并且女性更常见(男 vs 女:72% vs. 45%; p = .011)。38(38.3%)名患者对性感觉的改变需要超级强烈的支持。分层研究显示,与两者关系质量(R(2)  = 0.256)相关的因素包括:关系持续时间(β = -0.224)、疾病严重程度 (β = 0.325)、性满意度 (β = 0.409)。以下因素与性满意度(R(2)  = 0.344)相关:生理功能(β = 0.419)、对关系的满意度(β = 0.428)、男性 (β = -0.175)。性需求 (R(2)  = 0.436) 与疲劳(β = 0.232)、性满意度(β = -0.522)有关。

年轻癌症患者虽然对其与伴侣关系的评价普遍很高,但是该类人群依然经历着性困扰,需要针对性的支持。大部分病人因为性的改变而饱受压力,因此在性行为后需要及时的沟通和干预,尤其是对女性患者。

原始出处:


Geue K, Schmidt R, Sender A,et al.Sexuality and romantic relationships in young adult cancer survivors: satisfaction and supportive care needs.Psychooncology. 2015 Nov;24(11):1368-76.

版权声明:
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料,版权均属于梅斯医学所有。非经授权,任何媒体、网站或个人不得转载,授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章,或“梅斯号”自媒体发布的文章,仅系出于传递更多信息之目的,本站仅负责审核内容合规,其内容不代表本站立场,本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系,我们将立即进行删除处理。
在此留言
评论区 (6)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1864728, encodeId=77bc1864e28f2, content=<a href='/topic/show?id=16ce133504e' target=_blank style='color:#2F92EE;'>#Oncol#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=56, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=13350, encryptionId=16ce133504e, topicName=Oncol)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=b63894, createdName=minlingfeng, createdTime=Fri Sep 16 21:04:00 CST 2016, time=2016-09-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1674379, encodeId=099716e43791e, content=<a href='/topic/show?id=e8aa13359b1' target=_blank style='color:#2F92EE;'>#Oncology#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=59, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=13359, encryptionId=e8aa13359b1, topicName=Oncology)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=cb7226973259, createdName=circumcision, createdTime=Wed Aug 10 02:04:00 CST 2016, time=2016-08-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1289479, encodeId=f16c12894e92a, content=<a href='/topic/show?id=cbb8e1356f7' target=_blank style='color:#2F92EE;'>#癌症患者#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=53, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=71356, encryptionId=cbb8e1356f7, topicName=癌症患者)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=10ba218, createdName=zgwhgch, createdTime=Tue Nov 03 12:04:00 CST 2015, time=2015-11-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1308433, encodeId=e411130843308, content=<a href='/topic/show?id=b387526990e' target=_blank style='color:#2F92EE;'>#性福#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=74, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=52699, encryptionId=b387526990e, topicName=性福)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=76fa353, createdName=tm10051981, createdTime=Tue Nov 03 12:04:00 CST 2015, time=2015-11-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=42307, encodeId=33894230e7f, content=文章前沿, beContent=null, objectType=article, channel=null, level=null, likeNumber=154, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=2be01625436, createdName=fatalmelanie, createdTime=Mon Nov 02 15:48:00 CST 2015, time=2015-11-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=42308, encodeId=62ce423080a, content=课程精彩, beContent=null, objectType=article, channel=null, level=null, likeNumber=126, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=2be01625436, createdName=fatalmelanie, createdTime=Mon Nov 02 15:48:00 CST 2015, time=2015-11-02, status=1, ipAttribution=)]
    2016-09-16 minlingfeng
  2. [GetPortalCommentsPageByObjectIdResponse(id=1864728, encodeId=77bc1864e28f2, content=<a href='/topic/show?id=16ce133504e' target=_blank style='color:#2F92EE;'>#Oncol#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=56, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=13350, encryptionId=16ce133504e, topicName=Oncol)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=b63894, createdName=minlingfeng, createdTime=Fri Sep 16 21:04:00 CST 2016, time=2016-09-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1674379, encodeId=099716e43791e, content=<a href='/topic/show?id=e8aa13359b1' target=_blank style='color:#2F92EE;'>#Oncology#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=59, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=13359, encryptionId=e8aa13359b1, topicName=Oncology)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=cb7226973259, createdName=circumcision, createdTime=Wed Aug 10 02:04:00 CST 2016, time=2016-08-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1289479, encodeId=f16c12894e92a, content=<a href='/topic/show?id=cbb8e1356f7' target=_blank style='color:#2F92EE;'>#癌症患者#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=53, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=71356, encryptionId=cbb8e1356f7, topicName=癌症患者)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=10ba218, createdName=zgwhgch, createdTime=Tue Nov 03 12:04:00 CST 2015, time=2015-11-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1308433, encodeId=e411130843308, content=<a href='/topic/show?id=b387526990e' target=_blank style='color:#2F92EE;'>#性福#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=74, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=52699, encryptionId=b387526990e, topicName=性福)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=76fa353, createdName=tm10051981, createdTime=Tue Nov 03 12:04:00 CST 2015, time=2015-11-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=42307, encodeId=33894230e7f, content=文章前沿, beContent=null, objectType=article, channel=null, level=null, likeNumber=154, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=2be01625436, createdName=fatalmelanie, createdTime=Mon Nov 02 15:48:00 CST 2015, time=2015-11-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=42308, encodeId=62ce423080a, content=课程精彩, beContent=null, objectType=article, channel=null, level=null, likeNumber=126, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=2be01625436, createdName=fatalmelanie, createdTime=Mon Nov 02 15:48:00 CST 2015, time=2015-11-02, status=1, ipAttribution=)]
  3. [GetPortalCommentsPageByObjectIdResponse(id=1864728, encodeId=77bc1864e28f2, content=<a href='/topic/show?id=16ce133504e' target=_blank style='color:#2F92EE;'>#Oncol#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=56, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=13350, encryptionId=16ce133504e, topicName=Oncol)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=b63894, createdName=minlingfeng, createdTime=Fri Sep 16 21:04:00 CST 2016, time=2016-09-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1674379, encodeId=099716e43791e, content=<a href='/topic/show?id=e8aa13359b1' target=_blank style='color:#2F92EE;'>#Oncology#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=59, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=13359, encryptionId=e8aa13359b1, topicName=Oncology)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=cb7226973259, createdName=circumcision, createdTime=Wed Aug 10 02:04:00 CST 2016, time=2016-08-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1289479, encodeId=f16c12894e92a, content=<a href='/topic/show?id=cbb8e1356f7' target=_blank style='color:#2F92EE;'>#癌症患者#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=53, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=71356, encryptionId=cbb8e1356f7, topicName=癌症患者)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=10ba218, createdName=zgwhgch, createdTime=Tue Nov 03 12:04:00 CST 2015, time=2015-11-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1308433, encodeId=e411130843308, content=<a href='/topic/show?id=b387526990e' target=_blank style='color:#2F92EE;'>#性福#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=74, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=52699, encryptionId=b387526990e, topicName=性福)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=76fa353, createdName=tm10051981, createdTime=Tue Nov 03 12:04:00 CST 2015, time=2015-11-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=42307, encodeId=33894230e7f, content=文章前沿, beContent=null, objectType=article, channel=null, level=null, likeNumber=154, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=2be01625436, createdName=fatalmelanie, createdTime=Mon Nov 02 15:48:00 CST 2015, time=2015-11-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=42308, encodeId=62ce423080a, content=课程精彩, beContent=null, objectType=article, channel=null, level=null, likeNumber=126, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=2be01625436, createdName=fatalmelanie, createdTime=Mon Nov 02 15:48:00 CST 2015, time=2015-11-02, status=1, ipAttribution=)]
  4. [GetPortalCommentsPageByObjectIdResponse(id=1864728, encodeId=77bc1864e28f2, content=<a href='/topic/show?id=16ce133504e' target=_blank style='color:#2F92EE;'>#Oncol#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=56, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=13350, encryptionId=16ce133504e, topicName=Oncol)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=b63894, createdName=minlingfeng, createdTime=Fri Sep 16 21:04:00 CST 2016, time=2016-09-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1674379, encodeId=099716e43791e, content=<a href='/topic/show?id=e8aa13359b1' target=_blank style='color:#2F92EE;'>#Oncology#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=59, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=13359, encryptionId=e8aa13359b1, topicName=Oncology)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=cb7226973259, createdName=circumcision, createdTime=Wed Aug 10 02:04:00 CST 2016, time=2016-08-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1289479, encodeId=f16c12894e92a, content=<a href='/topic/show?id=cbb8e1356f7' target=_blank style='color:#2F92EE;'>#癌症患者#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=53, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=71356, encryptionId=cbb8e1356f7, topicName=癌症患者)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=10ba218, createdName=zgwhgch, createdTime=Tue Nov 03 12:04:00 CST 2015, time=2015-11-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1308433, encodeId=e411130843308, content=<a href='/topic/show?id=b387526990e' target=_blank style='color:#2F92EE;'>#性福#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=74, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=52699, encryptionId=b387526990e, topicName=性福)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=76fa353, createdName=tm10051981, createdTime=Tue Nov 03 12:04:00 CST 2015, time=2015-11-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=42307, encodeId=33894230e7f, content=文章前沿, beContent=null, objectType=article, channel=null, level=null, likeNumber=154, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=2be01625436, createdName=fatalmelanie, createdTime=Mon Nov 02 15:48:00 CST 2015, time=2015-11-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=42308, encodeId=62ce423080a, content=课程精彩, beContent=null, objectType=article, channel=null, level=null, likeNumber=126, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=2be01625436, createdName=fatalmelanie, createdTime=Mon Nov 02 15:48:00 CST 2015, time=2015-11-02, status=1, ipAttribution=)]
    2015-11-03 tm10051981
  5. [GetPortalCommentsPageByObjectIdResponse(id=1864728, encodeId=77bc1864e28f2, content=<a href='/topic/show?id=16ce133504e' target=_blank style='color:#2F92EE;'>#Oncol#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=56, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=13350, encryptionId=16ce133504e, topicName=Oncol)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=b63894, createdName=minlingfeng, createdTime=Fri Sep 16 21:04:00 CST 2016, time=2016-09-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1674379, encodeId=099716e43791e, content=<a href='/topic/show?id=e8aa13359b1' target=_blank style='color:#2F92EE;'>#Oncology#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=59, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=13359, encryptionId=e8aa13359b1, topicName=Oncology)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=cb7226973259, createdName=circumcision, createdTime=Wed Aug 10 02:04:00 CST 2016, time=2016-08-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1289479, encodeId=f16c12894e92a, content=<a href='/topic/show?id=cbb8e1356f7' target=_blank style='color:#2F92EE;'>#癌症患者#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=53, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=71356, encryptionId=cbb8e1356f7, topicName=癌症患者)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=10ba218, createdName=zgwhgch, createdTime=Tue Nov 03 12:04:00 CST 2015, time=2015-11-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1308433, encodeId=e411130843308, content=<a href='/topic/show?id=b387526990e' target=_blank style='color:#2F92EE;'>#性福#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=74, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=52699, encryptionId=b387526990e, topicName=性福)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=76fa353, createdName=tm10051981, createdTime=Tue Nov 03 12:04:00 CST 2015, time=2015-11-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=42307, encodeId=33894230e7f, content=文章前沿, beContent=null, objectType=article, channel=null, level=null, likeNumber=154, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=2be01625436, createdName=fatalmelanie, createdTime=Mon Nov 02 15:48:00 CST 2015, time=2015-11-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=42308, encodeId=62ce423080a, content=课程精彩, beContent=null, objectType=article, channel=null, level=null, likeNumber=126, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=2be01625436, createdName=fatalmelanie, createdTime=Mon Nov 02 15:48:00 CST 2015, time=2015-11-02, status=1, ipAttribution=)]
    2015-11-02 fatalmelanie

    文章前沿

    0

  6. [GetPortalCommentsPageByObjectIdResponse(id=1864728, encodeId=77bc1864e28f2, content=<a href='/topic/show?id=16ce133504e' target=_blank style='color:#2F92EE;'>#Oncol#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=56, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=13350, encryptionId=16ce133504e, topicName=Oncol)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=b63894, createdName=minlingfeng, createdTime=Fri Sep 16 21:04:00 CST 2016, time=2016-09-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1674379, encodeId=099716e43791e, content=<a href='/topic/show?id=e8aa13359b1' target=_blank style='color:#2F92EE;'>#Oncology#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=59, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=13359, encryptionId=e8aa13359b1, topicName=Oncology)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=cb7226973259, createdName=circumcision, createdTime=Wed Aug 10 02:04:00 CST 2016, time=2016-08-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1289479, encodeId=f16c12894e92a, content=<a href='/topic/show?id=cbb8e1356f7' target=_blank style='color:#2F92EE;'>#癌症患者#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=53, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=71356, encryptionId=cbb8e1356f7, topicName=癌症患者)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=10ba218, createdName=zgwhgch, createdTime=Tue Nov 03 12:04:00 CST 2015, time=2015-11-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1308433, encodeId=e411130843308, content=<a href='/topic/show?id=b387526990e' target=_blank style='color:#2F92EE;'>#性福#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=74, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=52699, encryptionId=b387526990e, topicName=性福)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=76fa353, createdName=tm10051981, createdTime=Tue Nov 03 12:04:00 CST 2015, time=2015-11-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=42307, encodeId=33894230e7f, content=文章前沿, beContent=null, objectType=article, channel=null, level=null, likeNumber=154, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=2be01625436, createdName=fatalmelanie, createdTime=Mon Nov 02 15:48:00 CST 2015, time=2015-11-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=42308, encodeId=62ce423080a, content=课程精彩, beContent=null, objectType=article, channel=null, level=null, likeNumber=126, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=2be01625436, createdName=fatalmelanie, createdTime=Mon Nov 02 15:48:00 CST 2015, time=2015-11-02, status=1, ipAttribution=)]
    2015-11-02 fatalmelanie

    课程精彩

    0

相关资讯

癌症小百科:历史,现状和未来点点滴滴

(一)进步和困境 一不小心跳进 “二十一世纪是生物的世纪” 这个大坑已经有十多年了,这么多年来,从本科到博士,从中国到美国,从学校到药厂,第一手,第二手,第N手的癌症研究资料接触很多。随着中国污染加剧,医疗条件改善和人们健康意识增加,周围患上癌症的人似乎越来越多。病人多,问题就多,谣言也多,鉴于最近时不时都有人咨询我各种各样关于癌症的问题,我觉得写一些科普小知识也许有些意义。朋友中很

Psychooncology:工作可提高癌症患者生活质量

全球范围内癌症人群数量与日俱增,在人口死亡原因分析上,癌症也占了一大块江山。随着医疗的发展,癌症生存率有所提高,癌症患者的寿命相对延长,不过诊断却越来越年轻化。很多人在工作期间就诊断为癌症,之后应该辞职还是继续工作?有研究表明,癌症患者的工作状态会对其健康相关的生活质量 (HRQOL)造成显著影响。研究者纳入了2007-2012年间韩国27,089名患者,探究在长期存活的癌症患者其工作状态对HRQ

Psychooncology:癌症患者的孤独感研究

研究者已对老年癌症患者的社会和情感孤独的频率和演变情况(分别与年轻癌症患者和老年非癌症患者相比)进行了研究。目前该研究团队欲探究癌症和年龄相关改变如疲劳、认知功能和功能状态,是否会对“孤独”造成影响。该研究为KLIMOP研究的一部分,包含老年癌症患者 (≥70 岁)、相对年轻的癌症患者 (50-69 岁)、以及老年非癌症患者。研究者采集了参与者的基线资料和随访1年后的资料。根据De Jong-Gi

Psychooncology:“写作”可以改善癌症患者的心理和身体健康吗?

研究者进行了一项系统评价和荟萃分析,评估写作表达的干预 (EWI)能都改善癌症患或幸存者的心理和身体健康情况。研究者检索了各大数据库,关于EWI对心理和身体健康影响的随机对照试验(1986-2014)。最终该研究共纳入了16篇独立的随机对照试验(1999-2014),探究了EWI对心理和身体健康影响有效性的文章。研究数据显示,EWI对个体或整体的心理健康并没有改善(Hedges's g: 0.04

BMC Medicine:女性生殖因素与其健康状况密切相关

发表在BMC Medicine的最新研究结果表明,女性的某些生殖因素可降低女性早期死亡的风险。 生殖功能与女性内分泌系统的变化与调节密切相关。具有生殖功能对女性而言具有十分重要的意义。既往研究表明,个别生殖因素与所有类型的死亡原因或多或少都存在一定的关联,并会增加一些特定疾病的死亡风险。但是,对于生殖因素对女性长期体质和身体健康的影响,研究人员尚未可知。鉴于这些因素彼此之间都有着紧密的联系,研究人

Baidu
map
Baidu
map
Baidu
map